5:29 PM
 | 
Oct 18, 2013
 |  BC Extra  |  Company News

Eddingpharm gets Chinese rights to ALX-0141 from Ablynx

Ablynx N.V. (Euronext:ABLX) granted Eddingpharm Inc. (Shanghai, China) exclusive rights in China and Taiwan to develop and commercialize ALX-0141, which has...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >